KemNet provides pharmacists with quality revision of popular pharmaceuticals that are more beneficial to certain patient groups.
KemNet has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in August 2022.
KemNet's investors include Y Combinator.
KemNet is headquartered in Edmonton, Canada.
KemNet provides pharmacists with quality revision of popular pharmaceuticals that are more beneficial to certain patient groups.
KemNet is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KemNet — Funding & Investors." VCBacked, August 22, 2022, https://www.vcbacked.co/company/kemnet. Accessed August 14, 2026.
VCBacked. (2022). KemNet — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kemnet
{{cite web |title=KemNet — Funding & Investors |url=https://www.vcbacked.co/company/kemnet |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated